An Antibody-armored Dendritic Cell in Patients With Solid Tumors

NCT07479667 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
8
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Shanghai Cell Therapy Group Co.,Ltd